pharma news today glp-1 obesity drug updates Major global in July 2026 feature massive market movements in the and segments, multi-billion dollar M&A deals, and new clinical milestones in regenerative and Lilly orforglipron oral GLP-1 phase

GHRH tells the pituitary gland to release Growth Hormone (GH)

Hope for PCOS While the results from this study of 180 women are preliminary, the impeccable safety profile for NAC and the promising findings in multiple parameters (number of follicles, endometrial thickness, ovulation and pregnancy rates) suggest it may benefit women with PCOS, especially in combination with Clomid

If you have been seeing new names like retatrutide, semaglutide, and tirzepatide, you are not alone

Mr Nizamoglu or Mr Shiatis will assess suitability at consultation based on the following criteria: Male patients, typically aged 2550 HD Lipo can be performed on women but the technique and goals differ

In the interaction of GSH with ROS, GSH serves as an electron donor

Raval AD et al